Tag Archives: PFIZER EXPECTS UPDATED COVID-19 VACCINE DATA FOR KIDS UNDER 5 BY APRIL

Pfizer Inc expects the latest results from a clinical trial for kids under the age of 5 of the COVID-19 vaccine it developed with Germany’s BioNTech SE by April, a top company scientist said on Wednesday. “The study has been amended to give a third dose to everybody who’s less than five at least eight weeks after their last vaccination,” …

Read More »